- Home
- JPI vs GRAL Comparison
JPI vs GRAL Comparison
Compare JPI & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JPI
- GRAL
- Stock Information
- Founded
- JPI 2012
- GRAL 2016
- Country
- JPI United States
- GRAL United States
- Employees
- JPI N/A
- GRAL N/A
- Industry
- JPI Finance Companies
- GRAL
- Sector
- JPI Finance
- GRAL
- Exchange
- JPI Nasdaq
- GRAL NYSE
- Market Cap
- JPI 482.8M
- GRAL 449.6M
- IPO Year
- JPI N/A
- GRAL N/A
- Fundamental
- Price
- JPI $20.42
- GRAL $14.80
- Analyst Decision
- JPI
- GRAL Hold
- Analyst Count
- JPI 0
- GRAL 1
- Target Price
- JPI N/A
- GRAL N/A
- AVG Volume (30 Days)
- JPI 54.7K
- GRAL 552.6K
- Earning Date
- JPI 01-01-0001
- GRAL 11-12-2024
- Dividend Yield
- JPI 6.15%
- GRAL N/A
- EPS Growth
- JPI N/A
- GRAL N/A
- EPS
- JPI N/A
- GRAL N/A
- Revenue
- JPI N/A
- GRAL $117,669,000.00
- Revenue This Year
- JPI N/A
- GRAL N/A
- Revenue Next Year
- JPI N/A
- GRAL N/A
- P/E Ratio
- JPI N/A
- GRAL N/A
- Revenue Growth
- JPI N/A
- GRAL 111.83
- 52 Week Low
- JPI $16.02
- GRAL $12.33
- 52 Week High
- JPI $19.12
- GRAL $23.36
- Technical
- Relative Strength Index (RSI)
- JPI 37.47
- GRAL N/A
- Support Level
- JPI $20.93
- GRAL N/A
- Resistance Level
- JPI $21.33
- GRAL N/A
- Average True Range (ATR)
- JPI 0.30
- GRAL 0.00
- MACD
- JPI -0.09
- GRAL 0.00
- Stochastic Oscillator
- JPI 37.88
- GRAL 0.00
About JPI Nuveen Preferred and Income Term Fund of Beneficial Interest
Nuveen Preferred and Income Term Fund is a closed-end management investment company. Its investment objective is to provide a high level of current income and total return. The company's products include mutual funds, closed-end funds, Exchange-traded funds, Multi-asset model portfolios, and others.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.